TIGIT and breast carcinoma: Multiple IRs expression, such as PD-1, PD-L1, TIGIT, and CTLA4, was reported in detail in TILs and circulating T cells in primary breast cancer and colorectal cancer in which immune checkpoint expression was correlated with promoter demethylation and post-translational histone modifications (130–134).